1Y Close · As of Aug 26, 2026
Hanmi Pharm operates in the Pharmaceuticals sector.
Legal name: Hanmi Pharm. Co., Ltd.
In fiscal year 2025, Hanmi Pharm (128940) reported revenue of 1.55 trillion KRW, up 3.5% from 1.50 trillion KRW a year earlier.
Operating profit was 257.8 billion KRW and net income was 187.1 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 6.79 trillion KRW, with a P/B of 4.77.
These figures can be verified in the DART filing (receipt no. 20260320001130).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 1.5T | 257.8B | 187.1B |
| 2024 | 1.5T | 216.2B | 140.4B |
| 2023 | 1.5T | 220.7B | 165.4B |
Recent Filings
Material Business Matters
Semi-Annual Report (2026.06)
Large Shareholding Report (General)
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: Treasury stock filings in the last 3 years: 2 disposal(s).
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-24 | Material Business Matters |
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-12 | Large Shareholding Report (General) |
| 2026-08-11 | Largest Shareholder Change Report |
| 2026-08-11 | Officer/Major Shareholder Ownership Report |